STOCK TITAN

Artivion (AORT) SVP and General Counsel sells 977 shares in open-market trade

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Jean F. Holloway, SVP and General Counsel of Artivion, Inc., reported a sale of 977 shares of Artivion common stock on 2026-08-12 in a transaction categorized as a "Sale in open market or private transaction" at a price of $28.49 per share. Following this sale, Holloway directly holds 184,118 shares of Artivion common stock. The filing’s Rule 10b5-1 checkbox is unchecked, and a footnote states that the reported price reflects the price at which the shares were sold.

Positive

  • None.

Negative

  • None.
Insider Holloway Jean F
Role SVP, General Counsel
Sold 977 shs ($28K)
Type Security Shares Price Value
Sale Common Stock F1 977 $28.49 $28K
Holdings After Transaction: Common Stock — 184,118 shares (Direct)
Footnotes (1)
  1. F1. Reflects the price the shares were sold.
Shares sold 977 shares Common stock sale reported for 2026-08-12
Sale price per share $28.49 Price at which the 977 shares were sold
Shares held after transaction 184,118 shares Direct holdings of Jean F. Holloway after the sale
Sell transactions in filing 1 sale One non-derivative sale transaction reported
Sale in open market or private transaction financial
"Transaction code description: Sale in open market or private transaction"
Rule 10b5-1 checkbox regulatory
"The filing’s Rule 10b5-1 checkbox is unchecked"
direct or indirect ownership financial
"direct_or_indirect uses D/I for Direct/Indirect ownership type"

FAQ

What insider transaction did AORT report for Jean F. Holloway?

Artivion (AORT) reported that Jean F. Holloway, SVP and General Counsel, sold 977 shares of common stock on 2026-08-12 in an open market or private transaction.

At what price did Jean F. Holloway sell AORT shares?

Jean F. Holloway sold 977 AORT shares at a price of $28.49 per share. A footnote explains that this figure reflects the price at which the shares were sold.

How many AORT shares does Jean F. Holloway hold after this Form 4 sale?

After the reported sale, Jean F. Holloway directly holds 184,118 shares of Artivion common stock. This post-transaction holding is disclosed in the Form 4 data.

Was Jean F. Holloway’s AORT share sale under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is unchecked, and no footnote indicates a trading plan, so the sale is not affirmed as occurring under a Rule 10b5-1 plan.

How many total shares were sold in this AORT Form 4 transaction?

The Form 4 for Artivion (AORT) reports a single sale transaction involving 977 shares of common stock, categorized as a sale in the open market or a private transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holloway Jean F

(Last)(First)(Middle)
1655 ROBERTS BLVD., NW

(Street)
KENNESAW GEORGIA 30144

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/12/2026S977D$28.49(1)184,118D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects the price the shares were sold.
Remarks:
/s/ Jean F Holloway08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)